MedPath

Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

Not Applicable
Completed
Conditions
Sexual Risk
Substance Use
Interventions
Behavioral: YMHP Intervention
Behavioral: Enhanced Treatment as Usual
Registration Number
NCT03488914
Lead Sponsor
Hunter College of City University of New York
Brief Summary

This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.

Detailed Description

We will conduct a comparative effectiveness trial (CET) with two intensities of treatment to be offered following field-based HIV counseling and testing (C\&T) - the young men's health project (YMHP) intervention and an enhanced "treatment as usual" (eTAU) condition involving HIV prevention services provided at two community based organizations (CBOs) to test their relative effectiveness in reducing substance use and sexual risk behavior among HIV-negative YMSM. In collaboration with two CBOs, our goals are to better understand substance use and sexual health-related outcomes among HIV-negative YMSM who are unlikely to be treatment seeking and to implement the YMHP intervention in a way that will maximize portability and scalability. Working together with our collaborators will help to address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce substance use and HIV infection among YMSM.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
86
Inclusion Criteria
  • HIV-negative test result from the past 90 days
  • 15-29 years of age
  • Born biologically male or currently identifying as male
  • Sex with men in the past 90 days
  • ≥ 5 days of illicit drug use in the past 90 days
  • ≥ 1 episode of condomless anal sex (CAS) in the past 90 days, or a positive sexually transmitted infection test result in the past 90 days.
  • Living in the New York City area
  • Able to communicate in English
Exclusion Criteria
  • Serious cognitive or psychiatric impairments
  • ≥5 days of injection drug use in the past 90 days
  • Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionYMHP InterventionThe YMHP intervention is a 4 session Motivational Interviewing (MI) intervention. In session 1, youth will choose which behavior to discuss first (substance use or sexual risk behavior), and the Health Educator counselor will elicit the client's view of the problem using standard MI techniques, building motivation for change by eliciting and reinforcing change talk, and clarifying the youth's own personal goals for maintaining their sexual health/considering changes in their substance use. The second session follows the same format for the second target behavior. In the subsequent two sessions, the counselor will discuss Pre-exposure Prophylaxis (PrEP) uptake as part of a change plan, continue to elicit and reinforce change talk, problem-solve barriers, consolidate commitment, and consider strategies to maintain behavior change.
Enhanced Treatment as UsualEnhanced Treatment as UsualThe Enhanced Treatment as Usual arm involves referring youth to standard of care services available at the community based organization for substance use and sexual health. This includes available services for Pre-exposure prophylaxis.
Primary Outcome Measures
NameTimeMethod
Condomless Anal Sex ActsBaseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of condomless anal sex acts with male partners in the past 90 days

Marijuana Use DaysBaseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of marijuana use days in the past 90 days

Illicit Drug Use DaysBaseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of illicit drug use days (not including marijuana) in the past 90 days

Secondary Outcome Measures
NameTimeMethod
Alcohol Use DaysBaseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of alcohol use days in the past 90 days

Trial Locations

Locations (2)

Bridging Access to Care

🇺🇸

Brooklyn, New York, United States

BOOM!Health

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath